First-of-kind Guillain-Barré drug switches off part of immune system

First-of-kind Guillain-Barré drug switches off part of immune system. A treatment that turns off the bit of the immune system that goes haywire in Guillain-Barré syndrome may be the first targeted therapy approved for the autoimmune condition

A apuração publicada por www.newscientist.com vira base para uma leitura editorial direta e contextualizada.

Trechos de apoio da pauta: A treatment that turns off the bit of the immune system that goes haywire in Guillain-Barré syndrome may be the first targeted therapy approved for the autoimmune condition

• Ponto de atenção: first.
• Ponto de atenção: kind.
• Ponto de atenção: guillain.

Em resumo, a leitura editorial acompanha o impacto do tema no nicho Ciência.